Integrating Clinical Biomarkers and Molecular Docking in Ischemic Stroke: A Multidisciplinary Approach
Journal of Bioscience Studies · 2026
DOI: 10.65761/jbs.2026.49 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Bioscience Studies, 2026. Verfasst von Saliha Mumtaz und 1 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Schlaganfall
Abstract (Originalsprache)
Background
Ischemic stroke is a major neurological disorder associated with dyslipidemia, oxidative stress, inflammation, and vascular injury. Integrating clinical biomarkers with computational approaches may provide broader insights into its underlying molecular mechanisms.
Objective
This study aimed to evaluate clinical and biochemical biomarkers associated with ischemic stroke and investigate the potential interactions of selected compounds with relevant protein targets using molecular docking and molecular dynamics simulations.
Methods
Ischemic stroke patients and healthy controls were evaluated for demographic and clinical characteristics, including blood pressure and BMI. Serum lipid parameters, oxLDL, oxHDL, SOD, apoC-III, IL-6, ferritin, LDH, uric acid, and apoB were assessed using biochemical and immunological methods. Statistical analyses included group comparisons, Spearman correlation, and multivariate logistic regression. Two relevant protein targets were subsequently subjected to molecular docking using AutoDock Vina, followed by molecular dynamics simulations using GROMACS.
Results
Stroke patients showed significantly increased atherogenic lipids, oxLDL, oxHDL, apoC-III, IL-6, ferritin, LDH, uric acid, and apoB, while SOD and HDL were reduced compared with controls. OxLDL, sdLDL, and IL-6 demonstrated significant associations with stroke. Docking identified favorable ligand–protein interactions, while molecular dynamics indicated stable protein–ligand complexes.
Conclusion
The integrated findings highlight the contribution of lipid abnormalities, oxidative stress, and inflammation to ischemic stroke and identify potentially relevant molecular interactions requiring further experimental validation.
Zitieren
APA
Mumtaz, S., & Fareed, A. (2026). Integrating Clinical Biomarkers and Molecular Docking in Ischemic Stroke: A Multidisciplinary Approach. Journal of Bioscience Studies. https://doi.org/10.65761/jbs.2026.49
Vancouver
Mumtaz S, Fareed A. Integrating Clinical Biomarkers and Molecular Docking in Ischemic Stroke: A Multidisciplinary Approach. Journal of Bioscience Studies. 2026. doi:10.65761/jbs.2026.49
BibTeX
@article{Mumtaz2026,
author = {Mumtaz, Saliha and Fareed, Ayesha},
title = {Integrating Clinical Biomarkers and Molecular Docking in Ischemic Stroke: A Multidisciplinary Approach},
journal = {Journal of Bioscience Studies},
year = {2026},
doi = {10.65761/jbs.2026.49}
}
EUVIMED